Fleur Serge Kanti

Dr. Fleur Serge Kanti

Auto-generated profile, based on publicly available information

Dr. Fleur Serge Kanti


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Environmental Research
Verified
Journal Article
Closed access
FKFleur Serge Kanti
Fleur Serge Kanti
AAAnna Alari
Anna Alari
BCBasile Chaix
Basile Chaix
TBTarik Benmarhnia
Tarik Benmarhnia

13 February 2024 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Open access
FKFleur Serge Kanti
Fleur Serge Kanti
RSRose Gorak Savard
Rose Gorak Savard
FBFrederic Bergeron
Frederic Bergeron
HZHervé Tchala Vignon Zomahoun
Hervé Tchala Vignon Zomahoun
ANAntoine Netter
Antoine Netter
SMSarah Maheux-Lacroix
Sarah Maheux-Lacroix
The diagnosis of endometriomas in patients with endometriosis is of primary importance because it influences the management and prognosis of infertility and pain. Imaging techniques are evolving constantly. This study aimed to systematically assess the diagnostic accuracy of transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI) in detecting endometrioma using the surgical visualisation of lesions with or without histopathological confirmation as reference standards in patients of reproductive age with suspected endometriosis. PubMed, Embase, Web of Science, Cumulative Index to Nursing and Allied Health Literature and ClinicalTrials.gov databases were searched from their inception to 12 October 2022, using a manual search for additional articles. Two authors independently performed title, abstract and full-text screening of the identified records, extracted study details and quantitative data and assessed the quality of the studies using the 'Quality Assessment of Diagnostic Accuracy Study 2' tool. Bivariate random-effects models were used to determine the pooled sensitivity and specificity, compare the two imaging modalities and evaluate the sources of heterogeneity. Sixteen prospective studies (10 assessing TVUS, 4 assessing MRI and 2 assessing both TVUS and MRI) were included, representing 1976 participants. Pooled TVUS and MRI sensitivities for endometrioma were 0.89 (95% confidence interval 'CI', 0.86-0.92) and 0.94 (95% CI, 0.74-0.99), respectively (indirect comparison p-value of 0.47). Pooled TVUS and MRI specificities for endometrioma were 0.95 (95% CI, 0.92-0.97) and 0.94 (95% CI, 0.89-0.97), respectively (indirect comparison p-value of 0.51). These studies had a high or unclear risk of bias. A direct comparison (all participants undergoing TVUS and MRI) of the modalities was available in only two studies. TVUS and MRI have high accuracy for diagnosing endometriomas; however, high-quality studies comparing the two modalities are lacking.

3 December 2024 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
FKFleur Serge Kanti
Fleur Serge Kanti
VAValérie Allard
Valérie Allard
AMAndrée‐Ann Métivier
Andrée‐Ann Métivier
MLMadeleine Lemyre
Madeleine Lemyre
KAKristina Arendas
Kristina Arendas
SMSarah Maheux‐Lacroix
Sarah Maheux‐Lacroix
Objective: To identify pain phenotypes in patients with endometriosis and investigate their associations with demographics, clinical characteristics, comorbidities and pain‐related quality of life (QoL).Design: Cross‐sectional, single‐centre, population‐based study.Setting: Referral university centre in Quebec City, Canada.Population: Patients diagnosed with endometriosis were enrolled consecutively between January 2020 and April 2024.Methods: Latent class analysis was used to identify pain phenotypes. A three‐step approach of latent class analysis, involving logistic regression models, was applied to assess the associations between pain phenotypes and demographics, clinical characteristics, comorbidities and pain‐related QoL.Main Outcome Measures: Pain phenotypes; demographic, clinical and comorbidity predictors of phenotype membership; association between QoL and pain phenotypes.Results: A total of 352 patients were included. Two pain phenotypes were identified with distinct clinical presentations: one (54% of the participants) with more severe and frequent pain symptoms and poorer QoL and the other (46% of the participants) with mild and less frequent pain symptoms. The high pain phenotype was associated with previous treatment failure, painkiller use, familial history of endometriosis, low annual family income and comorbidities, including painful bladder, fibromyalgia, migraines, lower back pain, irritable bowel syndrome, anxiety and depression or mood disorders. The presence of endometrioma was associated with the low pain phenotype. Phenotype membership was associated with distinct QoL profiles (p < 0.001). The mean QoL score was higher in the high pain phenotype (59; 95% CI, 56–62) than in the low pain phenotype (33; 95% CI, 29–37).Conclusion: Patients with endometriosis can be categorised into two distinct phenotypes that correlate with QoL and patient characteristics. Validation in other populations is necessary and could aid the development of specialised or personalised interventions.

27 January 2024 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
FKFleur Serge Kanti
Fleur Serge Kanti
VAValérie Allard
Valérie Allard
SMSarah Maheux-Lacroix
Sarah Maheux-Lacroix
Background: Endometriomas are genetically distinct from other endometriosis lesions and could be associated with a predisposition to excessive inflammation. However, differences in clinical presentation between types of endometriosis lesions have not been fully elucidated. This study aimed to investigate the quality of life and pain scores of patients with endometriomas compared to those with other types of endometriosis lesions. Methods: A cross-sectional observational study was conducted between January 2020 and August 2023. Patients diagnosed with endometriosis completed the Endometriosis Health Profile 30 pain subscale questionnaire for their quality of life score and rated their endometriosis-associated pain symptoms using an 11-point numerical rating scale. The data were analyzed for comparison through multivariate linear regression models. Results: A total of 248 patients were included and divided into endometrioma (81, 33%) and nonendometrioma (167, 67%) groups. The mean age of the patients was 37.1 ± 7.5 years. Most participants were Canadian or North American (84%). One-third of the patients reported experiencing up to four concurrent pain symptoms. The most reported pain included deep dyspareunia (90%), chronic pelvic pain (84%) and lower back pain (81%). The mean quality of life score was 45.9 ± 25.9. We observed no difference in quality of life scores between patients with and without endometriomas. Patients with endometriomas had lower mean scores for deep dyspareunia (0.8; 95% CI [0 to 1.5]; p = 0.049) and higher mean scores for superficial dyspareunia (1.4; 95% CI [0.2 to 2.6]; p = 0.028). Comorbid infertility (p = 0.049) was a factor that modified superficial dyspareunia intensity in patients with endometriomas. Conclusion: In patients with endometriosis, evidence was insufficient to conclude that the presence of endometriomas was not associated with a greater or lesser quality of life, but differences in specific symptoms of dyspareunia were identified.

9 March 2026
Verified
Preprint
Open access
SMSarah Maheux-Lacroix
Sarah Maheux-Lacroix
MLMadeleine Lemyre
Madeleine Lemyre
MBMarie-Ève Bergeron
Marie-Ève Bergeron
JGJenna Gale
Jenna Gale
FKFleur Serge Kanti
Fleur Serge Kanti
EBEmmanuel Bujold
Emmanuel Bujold
Objective To evaluate whether preovulatory intrauterine saline flushing, compared with a sham procedure, improves live birth in patients with unexplained infertility. Design A two-centre, triple-blind, parallel-group, superiority randomised controlled trial. Setting Two Canadian fertility clinics Population A total of 192 patients aged 18–37 years with unexplained infertility for at least 12 months. Methods Participants were randomised on the day of the luteinising hormone surge to receive either preovulatory intrauterine flushing with 20 mL of physiological saline (intervention) or a sham procedure consisting of 10 mL intravaginal saline (sham). Main Outcome Measures Live births (primary outcome) and pregnancies (secondary outcome) over one cycle of treatment. Results Ninety-six participants were assigned to each group, with no loss to follow up. Groups were comparable at baseline, including a mean age of 31.8 ±3.0 and 31.5 ± 3.3 years with 51 and 54% of primary infertility in the intervention and sham groups, respectively. Three live births occurred in each arm (relative risk [RR] 1.0; 95% confidence interval [CI] 0.2–4.8). One spontaneous abortion occurred in the sham group, with no difference between groups in pregnancy rates (RR 0.8; 95% CI 0.2–3.3). Pain during the procedure was more common in the intervention group (55% vs. 13%; p<0.001), although usually mild. No pelvic infections occurred, and severe pain was reported by only 1% (1/96) of participants in the intervention group. Conclusions Despite prior data suggesting uterine flushing as an effective treatment for unexplained infertility, this trial does not support its efficacy when performed with physiological saline.

27 February 2023
Verified
Preprint
Open access
CCClaire Cardaillac
Claire Cardaillac
RGRosalie Genest
Rosalie Genest
CGCaroline Gauthier
Caroline Gauthier
KAKristina Arendas
Kristina Arendas
MLMadeleine Lemyre
Madeleine Lemyre
SMSarah Maheux-Lacroix
Sarah Maheux-Lacroix
Background: Mechanical bowel preparation before gynecologic surgeries has been administered for decades but its use is controversial today. Objectives: To assess the efficacy and tolerance of mechanical bowel preparation before benign laparoscopic or vaginal gynecologic surgeries. Search strategy: MEDLINE (PubMed), EMBASE (OVID), Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Sciences published up to December 2021. Selection criteria: Randomized clinical trials in any language comparing mechanical bowel preparation before laparoscopic and vaginal gynecologic surgeries with no preparation were included. Data collection and analysis: Two reviewers independently screened and extracted data from selected articles and assessed the risk of bias. Surgeon findings, operative outcomes and patient’s pre-operative symptoms and satisfaction were collected. Main results: Twelve studies (1715 patients) of the 925 records screened were included. No significant differences were observed on surgical field view (RR=1.01, 95%CI 0.97-1.05, p=0.66, I 2 =0%); bowel handling (RR=1.01, 95%CI 0.95-1.08, p=0.78, I 2 =67%). There were no statistically significant differences in peri-operative findings. Mechanical bowel preparation was associated with increased pain (MD=11.62[2.80-20.44], I 2 =76, p=0.01); weakness (MD=10.73[0.60-20.87], I 2 =94, p=0.04); hunger (MD=17.52[8.04-27.00], I 2 =83, p=0.0003); insomnia (MD=10.13[0.57-19.68], I 2 =82, p=0.04); and lower satisfaction (RR=0.68 95%CI 0.53-0.87, I 2 =76%, p=0.002). Conclusion: In view of the adverse effects induced by mechanical bowel preparation and the lack of any surgical benefit, the routine its use prior to benign gynecological surgeries should be abandoned. Funding: This work was granted by the French network of University Hospitals HUGO and Fonds de recherche du Québec-Santé.